The report of Global Drug Eluting Balloon Market by Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, Others), Technology (Paccocath, FreePac, TransPax, EnduraCoat, Others), End-user (Hospitals & Ambulatory Surgery Centers, CATH Laboratories, Others), and Region (North America, Asia Pacific, Europe, South America, Middle East & Africa) is expected to reach US$ XX Mn by 2026, at a CAGR of XX% during a forecast period.
On the rise in the geriatric population and increasing occurrence of peripheral artery diseases (PAD) worldwide are major factors driving the growth of the drug eluting balloon market. Coronary artery diseases fail the heart muscle and can lead to heart failure and arrhythmias so, the growing prevalence of coronary artery diseases is another factor driving the growth of the drug eluting balloon market. Also, the drug eluting balloon is gaining acceptance amongst surgeons, as they are effective for the treatment of peripheral artery and coronary artery diseases. This balloon decreases the risk of stent failure is more effective in the treatment of superficial femoral artery (SFA).
An increase in R&D activities supported by government policies is expected to generate an opportunity for the coming years. On the other hand, the long-governing approval procedure, and major investment required on account of the high erosion rate in clinical trials are expected to hamper the market growth for the drug eluting balloon market.
Based on end-user,it has been fragmented into hospitals and ambulatory surgical centers, CATH labs, and others. Hospitals and ambulatory surgical centers are expected to boost the throughout the forecast period.
Region-wise, North America holds a significant share of XX% in the drug eluting balloon market during the forecast period. Thanks to increasing awareness about therapeutic applications of drug eluting balloons in coronary and peripheral artery diseases are driving the growth of the drug eluting balloon market in the North America region. As well, augmented investments by several foreign medical device companies have also pushed the growth of the drug eluting balloons market in this region.
Key players operating the Global Drug Eluting Balloon Market are Medtronic, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Incorporated, Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik, Inc.
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about. The report encompasses the market by different segments and regions, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics and future opportunities that might exist. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors has been taken into consideration for enhancing market know-how of our clients and at the same time explain positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Drug Eluting Balloon Market”
https://www.maximizemarketresearch.com/market-report/global-drug-eluting-balloon-market/40237/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908